News
New Clinical Evidence Workflow Solution From Wolters Kluwer Accelerates Research Activity Supporting Evidence-based Practice
Wolters Kluwer, Health today announced the launch of Ovid® Synthesis, a new suite of applications to power highly effective evidence-based workflows in the healthcare setting that complement Ovid’s
QIAGEN expands QIAstat-Dx syndromic testing menu and announces launch plans for new QIAstat-Dx Rise higher-throughput version
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced important enhancements in the commercialization of its QIAstat-Dx syndromic testing solution – which enables laboratories and
Reply Increases Its Presence in North America by Acquiring Enowa LLC and The Spur Group
REPLY [MTA, STAR: REY] strengthens its presence on the US market with the double acquisition of Enowa LLC (www.enowa.com) - a company specialized in consulting and development of solutions based on
NuStar to Participate in the 2022 UBS Winter Infrastructure & Energy Conference
NuStar Energy L.P. (NYSE: NS) announced today that members of management will participate in virtual meetings with members of the investment community at the 2022 UBS Winter Infrastructure & Energy
Global Market for IT and Business Services Turns in Record 2021, Even as Pace Slows in Q4, ISG Index™ Finds
The global market for technology and business services grew at its fastest pace ever, soaring to record heights in 2021, even as growth slowed in the fourth quarter, according to the latest
Avison Young and UiPath Partner to Drive Automation-Powered Real Estate Experiences
Avison Young, a technology-driven commercial real estate services firm and UiPath (NYSE: PATH), a leading enterprise automation software company, today announced a partnership to deliver the real
DGAP-News: Reply increases its presence in North America by acquiring Enowa LLC and The Spur Group
Genprex to Accelerate Opening of Acclaim-1 Clinical Trial Sites for REQORSA™ Systemic Gene Therapy in Non-Small Cell Lung Cancer
Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced
T-Mobile Acquires Rideshare Advertising Network, Octopus Interactive
T-Mobile (NASDAQ: TMUS) today announced the acquisition of Octopus Interactive, the largest national network of interactive video screens inside Uber and Lyft vehicles. This move marks the next
Upland Software Acquires Objectif Lune
Upland Software, Inc. (Nasdaq: UPLD) announced that it has acquired Objectif Lune Inc., an enterprise software leader in document composition and business communication automation. With the
Bill.com to Report Second Quarter Fiscal 2022 Financial Results on February 3, 2022
Bill.com (NYSE: BILL), a leading provider of cloud-based software that simplifies, digitizes, and automates back-office financial processes for small and midsized businesses (SMBs), will report
AMN Healthcare Announces Preliminary Fourth Quarter 2021 Revenue; To Present at J.P. Morgan Healthcare Conference
AMN Healthcare Services (NYSE: AMN) is providing preliminary unaudited consolidated revenue results for the fourth quarter of 2021 to facilitate the Company’s participation in the 40th Annual J.P
Guidewire Announces Aspire Systems, Inc. as New Consulting Alliance Partner
Guidewire (NYSE: GWRE) announced that Aspire Systems, Inc., a global technology services firm providing digital transformation services, has joined Guidewire PartnerConnect as a Consulting alliance
Guidewire Announces Aspire Systems, Inc. as new Consulting Alliance Partner
Guidewire (NYSE: GWRE) announced that Aspire Systems, Inc., a global technology services firm providing digital transformation services, has joined Guidewire PartnerConnect as a Consulting alliance
Clovis Oncology Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2021
Clovis Oncology, Inc. (NASDAQ:CLVS) today announced its preliminary, unaudited global product revenues for the fourth quarter and full year ended December 31, 2021. The financial information
Perion Network to Announce Fourth Quarter and Annual 2021 Financial Results on February 9, 2022
Perion Network Ltd. (NASDAQ:PERI) a global advertising technology company that delivers holistic solutions across the three main pillars of digital advertising – ad search, social media and display
Aptorum Group Announces Updates on the Clinical Validation of its RPIDD Infectious Disease Liquid Biopsy Technology
Regulatory News:
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company focused on novel technologies including
Aptorum Group Announces Completion of Phase I Clinical Trials for ALS-4 and SACT-1, Small Molecule Drugs Targeted for Infections Caused by Staphylococcus Aureus and Neuroblastoma
Regulatory News:
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, announces completion of the Phase I clinical
Aptorum Group Announces the Launch of its Oncology and Autoimmune Discovery and Development Platform Targeting Unmet Mutations and Novel Biomarkers
Regulatory News:
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, announces the launch of its oncology and
Agilent Presents Thought Leader Award to Professor Jason Kovacic
Agilent Technologies Inc. (NYSE: A) today announced that Professor Jason Kovacic has been selected to receive a prestigious Agilent Thought Leader Award. Professor Kovacic is being recognized for
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter 2021 and Summary Data from the Dexcom G7 U.S. Pivotal Trial
DexCom, Inc. (Nasdaq: DXCM), the leader in real-time continuous glucose monitoring (“CGM”), today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31
Scholar Rock Provides Corporate Update and Highlights Priorities for 2022
Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today provided recent
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Novocure Announces Preliminary Full Year and Fourth Quarter 2021 Net Revenues and Provides Company Update
Novocure (NASDAQ: NVCR) today reported preliminary unaudited financial results and operational updates for the quarter and full year ended December 31, 2021.* Novocure is a global oncology company
Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2022 Corporate Milestones
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, today provided a corporate